Investment Thesis
AMN Healthcare faces significant profitability challenges with negative operating and net margins despite maintaining positive free cash flow, indicating operational distress masked by working capital management. The company's leveraged balance sheet (1.19x debt-to-equity) combined with negative interest coverage and deteriorating revenue (-8.5% YoY) creates a precarious financial position vulnerable to further operational headwinds.
AMN Strengths
- Strong free cash flow generation of $233.8M despite unprofitable operations, demonstrating cash conversion capability
- Gross margin of 28.3% provides some buffer for cost management and operational improvements
- Positive operating cash flow of $269.5M shows underlying business can generate cash despite GAAP losses
AMN Risks
- Negative operating margin of -2.0% and net margin of -3.5% indicate core business is unprofitable at current revenue levels
- Revenue declining 8.5% year-over-year with no clear path to profitability suggests market headwinds or competitive pressures
- High leverage (1.19x debt-to-equity) with $767.1M long-term debt combined with negative interest coverage ratio of -3.3x creates refinancing and solvency risk
- Current ratio of 0.94x signals potential liquidity constraints; company cannot fully cover short-term obligations with current assets
- Negative ROE (-14.9%) and ROA (-4.6%) demonstrate shareholder capital is being eroded
Key Metrics to Watch
- Quarterly revenue trend and ability to stabilize market share
- Path to operating profitability and timeline to positive operating margin
- Free cash flow sustainability and debt reduction capability
- Current ratio improvement and working capital management
- Gross margin sustainability amid pricing and cost pressures
AMN Financial Metrics
AMN Profitability Ratios
AMN Balance Sheet & Liquidity
AMN 5-Year Financial Trend
5-Year Trend Summary: AMN HEALTHCARE SERVICES INC's revenue has remained relatively flat over the 5-year period, with a 5% decline. The most recent EPS of $5.36 reflects profitable operations.
AMN Growth Metrics (YoY)
AMN Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $634.5M | $7.0M | $0.18 |
| Q2 2025 | $658.2M | $16.2M | $0.42 |
| Q1 2025 | $689.5M | -$1.1M | $-0.03 |
| Q3 2024 | $687.5M | $7.0M | $0.18 |
| Q2 2024 | $740.7M | $16.2M | $0.42 |
| Q1 2024 | $820.9M | $17.3M | $0.45 |
| Q3 2023 | $853.5M | $53.2M | $1.39 |
| Q2 2023 | $991.3M | $60.9M | $1.55 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
AMN Capital Allocation
AMN SEC Filings
Access official SEC EDGAR filings for AMN HEALTHCARE SERVICES INC (CIK: 0001142750)